Drug Manufacturer Contacts
Contact details are available for drug companies participating in the Medicaid Drug Rebate Program. Each record includes an optional effective date, a termination date (if applicable), and legal, invoice, and technical contact information.
| Namelegal entity | Alternate Namelegal entity | Cityaddress | Stateaddress | ZIP Codeaddress | Street Addressaddress | Full Nameperson | Emailwebsite | Phonephone number | Labeler Coderegistration | Optional Eff. Datetemporal | Termination Datetemporal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAUSCH HEALTH US, LLC | BAUSCH HEALTH US, LLC | BRIDGEWATER | NJ | 8807 | 400 SOMERSET CORPORATE BLVD | SEANA CARSON | SEANA.CARSON@BAUSCHHEALTH.COM | 9056957634 | 99207 | 10011991 | 10012025 |
| Zameer Pharmaceuticals LLC | Zameer Pharmaceuticals LLC | Iselin | NJ | 8830 | 33 Wood Avenue South | Joel Mittelman | joel@zameerpharma.com | 7322109114 | 90096 | 3282022 | |
| UNITY PHARMA | Unity Pharma | Covina | CA | 91723 | 277 E Rowland St, | Shabana Yasmin | shabana@unitypharma.us | 6265362927 | 84275 | 1132025 | 7012025 |
Vendor Onboarding Verification for Specialty Pharmacy Networks
A specialty pharmacy or pharmacy benefit manager onboarding a new drug supplier checks whether the manufacturer holds an active Medicaid Drug Rebate Program registration, confirms the labeler code matches FDA records, and validates that the legal entity name and address on file align with the supplier's own documentation before executing a contract.
Rebate Processor Identity Mapping for Accounts Receivable Teams
A state Medicaid agency or managed care organization reconciling outstanding drug rebate payments identifies which third-party rebate processing firms are handling invoices on behalf of manufacturers, maps the correct invoice contact and address for each labeler, and flags cases where the invoicing entity differs from the registered manufacturer to prevent misdirected payments.
Market Exit Detection for Pharmaceutical Sales Intelligence
A market analytics firm tracking competitive dynamics in the generic or specialty drug market monitors termination dates and active status changes to identify manufacturers that have recently exited the Medicaid channel, which can signal product discontinuation, acquisition, or financial distress before those events appear in public filings.



















